首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
Authors:Albert Do  Yash Mittal  AnnMarie Liapakis  Elizabeth Cohen  Hong Chau  Claudia Bertuccio  Dana Sapir  Jessica Wright  Carol Eggers  Kristine Drozd  Maria Ciarleglio  Yanhong Deng  Joseph K Lim
Institution:1. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States of America.; 2. Yale Liver Center, Section of Digestive Diseases, New Haven, CT, United States of America.; 3. Liver Transplantation Program, Yale-New Haven Hospital, New Haven, CT, United States of America.; 4. Apothecary and Wellness Center, Yale-New Haven Hospital, New Haven, CT, United States of America.; University of North Carolina School of Medicine, UNITED STATES,
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号